The European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending approval of Keytruda (pembrolizumab) in combination with gemcitabine and cisplatin, for the first-line treatment of adult patients with locally advanced unresectable or metastatic biliary tract carcinoma.
Legend Biotech Ireland Limited, a wholly owned subsidiary of Legend Biotech, has entered into an exclusive, global license agreement with Novartis Pharma AG for certain Legend Biotech chimeric antigen receptor T-cell therapies targeting DLL3, including its autologous CAR-T cell therapy candidate, LB2102 (NCT05680922).
Monica M. Bertagnolli, the 16th NCI director, has been confirmed as the 17th director of NIH—six months after the White House first named her to lead the world’s largest public funder of biomedical research.
Today’s traditional research model relies on incremental innovation that builds upon the shoulders of other researchers’ work, making small but steady strides. Occasionally, leaps are made by researchers who develop new classes of therapy such as stem cell transplant or CAR-T immunotherapy. But cancer patients may not have the luxury to wait 20 years for the traditional scientific process to evolve for their cancer. They can’t wait for a cure.
MD Anderson Cancer Center launched its Institute for Data Science in Oncology, or IDSO, which integrates the most advanced computational and data science approaches with the institution’s extensive scientific and clinical expertise to significantly improve patient’s lives by transforming cancer care and research.
Alan H. Bryce was named chief clinical officer at City of Hope Cancer Center Phoenix and professor of molecular medicine at Translational Genomics Research Institute (TGen), part of City of Hope.
Craig D. Blinderman was named chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center.
Agnes Hsu, a clinical nurse, has received the 2023 Brown Foundation Award for Excellence in Oncology Nursing from MD Anderson Cancer Center.
Alexander Kutikov, chair of the Department of Urology and the Roberta R. Scheller Chair in Urologic Oncology at Fox Chase Cancer Center, will receive the Andrew C. Novick Award from the Kidney Cancer Association.
Temple University/Fox Chase Cancer Center and Hunter College of the City University of New York have received a five-year, $13.3 million grant renewal from NCI to address cancer health disparities.
